Prospective study of uveitis in children with juvenile idiopathic arthritis over a 3-year period

AbstractJuvenile idiopathic arthritis (JIA) is the most common systemic autoimmune disease in childhood, which can cause non-infectious uveitis. Ocular inflammation is the most severe, sight-threatening extra-articular complication. In this prospective three-year study 81 children with identified au...

Full description

Bibliographic Details
Main Authors: Malina Markova, Stefan Stefanov, Albena Teltcharova-Mihaylovska, Alexander Oscar
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13102818.2023.2179857
_version_ 1797367480043175936
author Malina Markova
Stefan Stefanov
Albena Teltcharova-Mihaylovska
Alexander Oscar
author_facet Malina Markova
Stefan Stefanov
Albena Teltcharova-Mihaylovska
Alexander Oscar
author_sort Malina Markova
collection DOAJ
description AbstractJuvenile idiopathic arthritis (JIA) is the most common systemic autoimmune disease in childhood, which can cause non-infectious uveitis. Ocular inflammation is the most severe, sight-threatening extra-articular complication. In this prospective three-year study 81 children with identified autoimmune diseases were observed of whom 56 were with JIA. Uveitis was observed in 21 of the children with JIA. All children were followed up for three years between December 2019 and November 2022 in the Department of Ophthalmology, University Hospital ‘Alexandrovska’ and the Department of Paediatric Rheumatology, University Children Hospital, Sofia, Bulgaria. Uveitis developed in 21 (37.5%) of 51 children diagnosed with JIA. Systemic immunosuppressive medications were more common among children with uveitis (31[38.27%]), compared to children without uveitis (27 [23.1%]). Ocular complications occurred in 15[26.78%] of the children with JIA. The early onset of uveitis after the diagnosis of JIA was a risk factor for developing ocular complications. Detected antinuclear antibodies (ANA) was also a risk factor for developing uveitis in children with JIA. The median age at the time of diagnosis of uveitis was 3.76 years. Our results support the recommendation that the screening for uveitis should start immediately when arthritis is suspected or confirmed and that all children with JIA should be monitored by an ophthalmologist every three to six months. Systemic immunosuppressive treatment in combination with biological therapy is considered early in the course of the disease in children with a high risk of developing ocular complications.
first_indexed 2024-03-08T17:18:54Z
format Article
id doaj.art-7900aa79535b4aaea91ecbeccebd9c12
institution Directory Open Access Journal
issn 1310-2818
1314-3530
language English
last_indexed 2024-03-08T17:18:54Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Biotechnology & Biotechnological Equipment
spelling doaj.art-7900aa79535b4aaea91ecbeccebd9c122024-01-03T09:44:12ZengTaylor & Francis GroupBiotechnology & Biotechnological Equipment1310-28181314-35302023-12-0137122623010.1080/13102818.2023.2179857Prospective study of uveitis in children with juvenile idiopathic arthritis over a 3-year periodMalina Markova0Stefan Stefanov1Albena Teltcharova-Mihaylovska2Alexander Oscar3Medical University of Sofia, Department of Ophthalmology, University Hospital Alexandrovska, Sofia, BulgariaDepartment of Paediatric Rheumatology, University Children’s Hospital, Medical University of Sofia, Sofa, BulgariaDepartment of Paediatric Rheumatology, University Children’s Hospital, Medical University of Sofia, Sofa, BulgariaMedical University of Sofia, Department of Ophthalmology, University Hospital Alexandrovska, Sofia, BulgariaAbstractJuvenile idiopathic arthritis (JIA) is the most common systemic autoimmune disease in childhood, which can cause non-infectious uveitis. Ocular inflammation is the most severe, sight-threatening extra-articular complication. In this prospective three-year study 81 children with identified autoimmune diseases were observed of whom 56 were with JIA. Uveitis was observed in 21 of the children with JIA. All children were followed up for three years between December 2019 and November 2022 in the Department of Ophthalmology, University Hospital ‘Alexandrovska’ and the Department of Paediatric Rheumatology, University Children Hospital, Sofia, Bulgaria. Uveitis developed in 21 (37.5%) of 51 children diagnosed with JIA. Systemic immunosuppressive medications were more common among children with uveitis (31[38.27%]), compared to children without uveitis (27 [23.1%]). Ocular complications occurred in 15[26.78%] of the children with JIA. The early onset of uveitis after the diagnosis of JIA was a risk factor for developing ocular complications. Detected antinuclear antibodies (ANA) was also a risk factor for developing uveitis in children with JIA. The median age at the time of diagnosis of uveitis was 3.76 years. Our results support the recommendation that the screening for uveitis should start immediately when arthritis is suspected or confirmed and that all children with JIA should be monitored by an ophthalmologist every three to six months. Systemic immunosuppressive treatment in combination with biological therapy is considered early in the course of the disease in children with a high risk of developing ocular complications.https://www.tandfonline.com/doi/10.1080/13102818.2023.2179857Non-infectious uveitisjuvenile idiopathic arthritisJIAchildrenpaedriatric ophthalmologyiridocyclitis
spellingShingle Malina Markova
Stefan Stefanov
Albena Teltcharova-Mihaylovska
Alexander Oscar
Prospective study of uveitis in children with juvenile idiopathic arthritis over a 3-year period
Biotechnology & Biotechnological Equipment
Non-infectious uveitis
juvenile idiopathic arthritis
JIA
children
paedriatric ophthalmology
iridocyclitis
title Prospective study of uveitis in children with juvenile idiopathic arthritis over a 3-year period
title_full Prospective study of uveitis in children with juvenile idiopathic arthritis over a 3-year period
title_fullStr Prospective study of uveitis in children with juvenile idiopathic arthritis over a 3-year period
title_full_unstemmed Prospective study of uveitis in children with juvenile idiopathic arthritis over a 3-year period
title_short Prospective study of uveitis in children with juvenile idiopathic arthritis over a 3-year period
title_sort prospective study of uveitis in children with juvenile idiopathic arthritis over a 3 year period
topic Non-infectious uveitis
juvenile idiopathic arthritis
JIA
children
paedriatric ophthalmology
iridocyclitis
url https://www.tandfonline.com/doi/10.1080/13102818.2023.2179857
work_keys_str_mv AT malinamarkova prospectivestudyofuveitisinchildrenwithjuvenileidiopathicarthritisovera3yearperiod
AT stefanstefanov prospectivestudyofuveitisinchildrenwithjuvenileidiopathicarthritisovera3yearperiod
AT albenateltcharovamihaylovska prospectivestudyofuveitisinchildrenwithjuvenileidiopathicarthritisovera3yearperiod
AT alexanderoscar prospectivestudyofuveitisinchildrenwithjuvenileidiopathicarthritisovera3yearperiod